1 week Ago By Defense World Staff
Prudential Financial Inc. decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 3.
8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,277 shares of the company’s stock after selling 676 shares during the period. Prudential Financial Inc.
’s holdings in Option Care Health were worth $379,000 as of its most recent filing with the Securities and Exchange Commission. Other hedge funds have also added to or reduced their stakes in the company. Advantage Alpha Capital Partners LP increased its stake in shares of Option Care Health by 26.
4% in the 4th quarter. Advantage Alpha Capital Partners LP now owns 120,091 shares of the company’s stock valued at $2,786,000 after purchasing an additional 25,070 shares during the last quarter. Vanguard Group Inc.
boosted its stake in Option Care Health by 0.4% in the fourth quarter. Vanguard Group Inc.
now owns 19,315,421 shares of the company’s stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Fox Run Management L.L.
C. bought a new position in Option Care Health in the fourth quarter valued at about $482,000. KLP Kapitalforvaltning AS acquired a new position in Option Care Health during the fourth quarter worth about $962,000.
Finally, American Century Companies Inc. lifted its holdings in shares of Option Care Health by 10.9% in the fourth quarter.
American Century Companies Inc. now owns 1,273,523 shares of the company’s stock worth $29,546,000 after acquiring an additional 125,107 shares during the last quarter. 98.
05% of the stock is owned by institutional investors. Option Care Health Trading Up 2.3 %NASDAQ OPCH opened at $33.
56 on Thursday. The firm has a market capitalization of $5.51 billion, a PE ratio of 28.
20, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.
The business’s 50-day moving average price is $33.17 and its two-hundred day moving average price is $28.58.
The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.
77. Option Care Health, Inc. has a 12 month low of $21.
39 and a 12 month high of $35.53. Insider Buying and SellingIn other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction that occurred on Friday, February 28th.
The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96.
Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.
80 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.
64% of the stock is owned by insiders. Wall Street Analysts Forecast GrowthOPCH has been the subject of a number of research analyst reports. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $26.
00 to $33.00 in a research report on Monday, January 13th. JMP Securities reiterated a “market outperform” rating and issued a $30.
00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $26.
00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co.
upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th.
Finally, Barrington Research lifted their price target on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th.
Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $33.00.
View Our Latest Stock Report on OPCHAbout Option Care Health (Free Report)Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.See AlsoFive stocks we like better than Option Care HealthTechnology Stocks Explained: Here’s What to Know About TechQuantum Computing: The $6.
5 Billion Opportunity You Can’t IgnoreBasic Materials Stocks InvestingAre Tariffs Threatening Disney’s Comeback Story?What is the Nasdaq? Complete Overview with HistoryIs Alphabet a Generational Buying Opportunity at These Levels?Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
.
